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S3
Quantification of modifications in RNA
As for the quantification of modifications in RNA, 1/10 of the enzymatically digested nucleosides was analyzed by HPLC with UV detection to quantify the amount of RNA. The calibration curves of the four canonical nucleosides (A, C, G and U) were constructed by plotting peak areas of canonical nucleosides against the molar amounts of canonical nucleosides with triplicate measurements.
The rest of 9/10 of the digested nucleosides were subjected to CMCT labelling and CeO 2 extraction followed by LC-ESI-MS/MS analysis. The amount of each modification was normalized with the amount of uridine quantified by HPLC analysis.
CeO 2 extraction of CMCT labelled nucleosides
The procedure of CeO 2 extraction was performed according to the previous study 1 .
Briefly, 600 mg of CeO 2 was added into a 5 mL centrifuge tube followed by sequential washing with 1 mL of 1% formic acid in water, 1 mL of water and 1 mL of 1% ammonia solution for 3 min each time. The sample mixture (110 μL) was diluted with 1% ammonia solution (2 mL) to 2.1 mL and then added into the tube and vortexed vigorously for 5 min. After centrifugation at 12,000 rpm for 4 min, the resulting CeO 2 with extracted compounds were sequentially washed with 2 mL water and 1 mL methanol for 3 min. Then 1 mL of 1% formic acid in water was used to elute the adsorbed compounds by vortexing for 3 min. The eluent was collected, lyophilized to dryness, and then dissolved in 50 μL water for subsequent LC-ESI-MS/MS analysis.
S4
In-vitro transcription of RNA
We synthesized a RNA strand by in-vitro transcription as the control sample. A 558-bp duplex DNA containing a T7 promoter was used as template for the in-vitro transcription according to previous study. 2 In-vitro transcription was performed in a 20-μL reaction mixture containing 100 ng of DNA template, 2 μL of 10 × reaction buffer, 1 μL of NTP (10 mM for each), 2 μL of DTT (50 mM) and 2 μL of T7 RNA polymerase (Sangon Biotech, Shanghai, China). The reaction was incubated at 37°C for 2 h and then 1 μL DNase (2 U) was added. The mixture was incubated at 37°C for 15 min to digest the template DNA. The in-vitro transcribed RNA was purified by chloroform extraction and isopropanol precipitation. The integrity of purified RNA was confirmed using 5% denaturing PAGE. The sequence of the in-vitro transcribed RNA is listed in Table S7 in Supporting Information.
Evaluation of the purity of isolated mRNA by real-time quantitative PCR
The polyA-extracted mRNA was further purified by 0.8% agarose gel of low melting point. The agarose gel electrophoresis was carried out with 0.5 × TBE at 130 V for 10 min.
Then the agarose gel was stained with GelRed (Invitrogen) and visualized by a gel The real-time quantitative PCR analysis demonstrated that the potential contamination of small RNA was less than 0.023% in mRNA ( Figure S8 in Supporting Information), i.e. less than 0.12 ng of small RNA in 500 ng of mRNA. We then analyzed m 5 U from 500 ng of mRNA.
The peak of m 5 U from 500 ng of mRNA was clear and distinct ( Figure S9 in Supporting Information). However, no signal of m 5 U was observed from 0.12 ng of small RNA ( Figure   S9 in Supporting Information), indicating that the m 5 U signal from 500 ng of mRNA indeed comes from mRNA, but not the trace level of small RNA.
Western blotting analysis of TRMT2A
The overexpression and siRNA knockdown of TRMT2A were examined by western blot.
Briefly, human HEK293T cell lysates were prepared using RIPA lysis buffer (Beyotime Biotech Inc., Shanghai, China). Protein concentration was measured by the BCA (bicinchoninic acid) assay according to the manufacture's recommended procedure (Beyotime Biotech Inc., Shanghai, China). Antibodies that specifically recognized TRMT2A (Abcam, ab205616, Cambridge, MA) and GAPDH (Abcam, ab181602, Cambridge, MA) were used at 1:2,000 and 1:8,000 dilutions, respectively. Horseradish peroxidase-conjugated secondary goat anti-rabbit antibody (Abcam, ab6721, Cambridge, MA) was used at a 1:10,000 dilution.
S7
Analysis of mRNA by high-throughput sequencing
The isolated mRNA was processed using KAPA Stranded RNA-Seq Library Prep Kit The results showed that 12299 genes were detected in the isolated mRNA (Table S5 in and was evaluated by examining tRNA HisGUG ; 18S rRNA was evaluated using the specific primers targeting 18S rRNA; 28S rRNA was evaluated using the specific primers targeting 28S rRNA. 
